Valens Semiconductor today announced the appointment of Yoram Salinger as its new Chief Executive Officer and board member, effective on November 13th, 2025. Salinger will succeed Gideon Ben-Zvi, who ...
Continued clinical execution of oncology strategy with focus on two pan-tumor programs, including combination approaches to address the full continuum of cancer from early to late disease stagesDemons ...
NEW YORK, Nov. 03, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX) (the Company or TG Therapeutics) today announced its financial results for the third quarter of 2025, along with recent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback